Universal pneumococcal 7-valent vaccination cost effective Clinical study 13 February 2013 Pages: 1 - 1
One-visit ICS testing dominates in prenatal syphilis screening News item 13 February 2013 Pages: 5 - 5
Clopidogrel utilisation altered by policy change in Canada Clinical study 13 February 2013 Pages: 6 - 6
Radiochemotherapy toxicity costly in HNC, NSCLC patients Clinical study 13 February 2013 Pages: 6 - 6
Contraceptive counselling needs work in renal transplant recipients Clinical study 13 February 2013 Pages: 7 - 7
Free treatment of Buruli ulcer still too costly in Cameroon Media release 13 February 2013 Pages: 7 - 7
Formulary coverage of targeted cancer therapies inconsistent Media release 13 February 2013 Pages: 8 - 8
Screening justified for relatives of factor V Leiden carriers Clinical study 13 February 2013 Pages: 9 - 9
Primary angioplasty the new first-line heart attack treatment in UK Media release 13 February 2013 Pages: 9 - 9
Dexlansoprazole shows benefits in healed erosive oesophagitis News item 13 February 2013 Pages: 10 - 10
A new programme will help patients continue to receive immune globulin [Gamunex] during lapses in private insurance. Media release 13 February 2013 Pages: 11 - 11
Sales of Genentech/Roche/Chugai's bevacizumab [Avastin] looks set to drive the breast cancer drug market Media release 13 February 2013 Pages: 11 - 11
Canadian patients with Parkinson's disease (PD) have received good news regarding levodopa/carbidopa/entacapone Media release 13 February 2013 Pages: 11 - 11